AIM
AIM ImmunoTech
13 hedge funds and large institutions have $420K invested in AIM ImmunoTech in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
Holders
13
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$19.3K | |
| 2 | +$12.3K | |
| 3 | +$8.77K | |
| 4 |
VF
Virtu Financial
New York
|
+$8.77K |
| 5 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$3.51K |
Top Sellers
| 1 | -$472K | |
| 2 | -$462K | |
| 3 | -$7.02K | |
| 4 |
Bank of New York Mellon
New York
|
-$5.26K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.75K |